Journal article 565 views 72 downloads
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secon...
BMJ Open, Volume: 12, Issue: 11, Start page: e063271
Swansea University Authors: Mike Seaborne , Ashley Akbari , Ronan Lyons , Sinead Brophy
-
PDF | Version of Record
© Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license
Download (965.74KB)
DOI (Published version): 10.1136/bmjopen-2022-063271
Abstract
Introduction SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP), but mild or asymptomatic infections are common. Persistent symptoms following infection have been reported in CYP but subsequent healthcare use is unclear. We aim to describe healthcare use in CYP fol...
Published in: | BMJ Open |
---|---|
ISSN: | 2044-6055 2044-6055 |
Published: |
BMJ
2022
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa61931 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2022-11-24T09:49:33Z |
---|---|
last_indexed |
2023-01-13T19:23:02Z |
id |
cronfa61931 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-11-24T09:53:05.6884120</datestamp><bib-version>v2</bib-version><id>61931</id><entry>2022-11-15</entry><title>Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales</title><swanseaauthors><author><sid>fcc7ece0f04577ad5f283b00dd7f52cf</sid><ORCID>0000-0002-4921-7556</ORCID><firstname>Mike</firstname><surname>Seaborne</surname><name>Mike Seaborne</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>83efcf2a9dfcf8b55586999d3d152ac6</sid><ORCID>0000-0001-5225-000X</ORCID><firstname>Ronan</firstname><surname>Lyons</surname><name>Ronan Lyons</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>84f5661b35a729f55047f9e793d8798b</sid><ORCID>0000-0001-7417-2858</ORCID><firstname>Sinead</firstname><surname>Brophy</surname><name>Sinead Brophy</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-11-15</date><deptcode>HDAT</deptcode><abstract>Introduction SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP), but mild or asymptomatic infections are common. Persistent symptoms following infection have been reported in CYP but subsequent healthcare use is unclear. We aim to describe healthcare use in CYP following community-acquired SARS-CoV-2 infection and identify those at risk of ongoing healthcare needs.Methods and analysis We will use anonymised individual-level, population-scale national data linking demographics, comorbidities, primary and secondary care use and mortality between 1 January 2019 and 1 May 2022. SARS-CoV-2 test data will be linked from 1 January 2020 to 1 May 2022. Analyses will use Trusted Research Environments: OpenSAFELY in England, Secure Anonymised Information Linkage (SAIL) Databank in Wales and Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 in Scotland (EAVE-II). CYP aged ≥4 and <18 years who underwent SARS-CoV-2 reverse transcription PCR (RT-PCR) testing between 1 January 2020 and 1 May 2021 and those untested CYP will be examined.The primary outcome measure is cumulative healthcare cost over 12 months following SARS-CoV-2 testing, stratified into primary or secondary care, and physical or mental healthcare. We will estimate the burden of healthcare use attributable to SARS-CoV-2 infections in the 12 months after testing using a matched cohort study of RT-PCR positive, negative or untested CYP matched on testing date, with adjustment for confounders. We will identify factors associated with higher healthcare needs in the 12 months following SARS-CoV-2 infection using an unmatched cohort of RT-PCR positive CYP. Multivariable logistic regression and machine learning approaches will identify risk factors for high healthcare use and characterise patterns of healthcare use post infection.Ethics and dissemination This study was approved by the South-Central Oxford C Health Research Authority Ethics Committee (13/SC/0149). Findings will be preprinted and published in peer-reviewed journals. Analysis code and code lists will be available through public GitHub repositories and OpenCodelists with meta-data via HDR-UK Innovation Gateway.</abstract><type>Journal Article</type><journal>BMJ Open</journal><volume>12</volume><journalNumber>11</journalNumber><paginationStart>e063271</paginationStart><paginationEnd/><publisher>BMJ</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2044-6055</issnPrint><issnElectronic>2044-6055</issnElectronic><keywords/><publishedDay>10</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-11-10</publishedDate><doi>10.1136/bmjopen-2022-063271</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>This research is part of the Data and Connectivity National Core Study,
led by Health Data Research UK in partnership with the Office for National Statistics
and funded by UK Research and Innovation (grant ref MC_PC_20058). This work
was also supported by The Alan Turing Institute via ‘Towards Turing 2.0’ EPSRC
Grant Funding. The grant period spans 1 November 2021 to 30 September 2022.</funders><projectreference/><lastEdited>2022-11-24T09:53:05.6884120</lastEdited><Created>2022-11-15T22:54:31.0560929</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Olivia V</firstname><surname>Swann</surname><orcid>0000-0001-7386-2849</orcid><order>1</order></author><author><firstname>Nazir I</firstname><surname>Lone</surname><order>2</order></author><author><firstname>Ewen M</firstname><surname>Harrison</surname><orcid>0000-0002-5018-3066</orcid><order>3</order></author><author><firstname>Laurie A</firstname><surname>Tomlinson</surname><orcid>0000-0001-8848-9493</orcid><order>4</order></author><author><firstname>Alex J</firstname><surname>Walker</surname><orcid>0000-0003-4932-6135</orcid><order>5</order></author><author><firstname>Mike</firstname><surname>Seaborne</surname><orcid>0000-0002-4921-7556</orcid><order>6</order></author><author><firstname>Louisa</firstname><surname>Pollock</surname><order>7</order></author><author><firstname>James</firstname><surname>Farrell</surname><order>8</order></author><author><firstname>Peter S</firstname><surname>Hall</surname><order>9</order></author><author><firstname>Sohan</firstname><surname>Seth</surname><order>10</order></author><author><firstname>Thomas C</firstname><surname>Williams</surname><order>11</order></author><author><firstname>Jennifer</firstname><surname>Preston</surname><order>12</order></author><author><firstname>J. Samantha</firstname><surname>Ainsworth</surname><order>13</order></author><author><firstname>Freya F</firstname><surname>Semple</surname><order>14</order></author><author><firstname>J Kenneth</firstname><surname>Baillie</surname><order>15</order></author><author><firstname>Srinivasa V</firstname><surname>Katikireddi</surname><orcid>0000-0001-6593-9092</orcid><order>16</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>17</order></author><author><firstname>Ronan</firstname><surname>Lyons</surname><orcid>0000-0001-5225-000X</orcid><order>18</order></author><author><firstname>Colin R</firstname><surname>Simpson</surname><orcid>0000-0002-5194-8083</orcid><order>19</order></author><author><firstname>Malcolm G</firstname><surname>Semple</surname><order>20</order></author><author><firstname>Ben</firstname><surname>Goldacre</surname><orcid>0000-0002-5127-4728</orcid><order>21</order></author><author><firstname>Sinead</firstname><surname>Brophy</surname><orcid>0000-0001-7417-2858</orcid><order>22</order></author><author><firstname>Aziz</firstname><surname>Sheikh</surname><order>23</order></author><author><firstname>Annemarie B</firstname><surname>Docherty</surname><order>24</order></author></authors><documents><document><filename>61931__25885__28f3ad11ed614fcb96afb2f4cca8c987.pdf</filename><originalFilename>61931.pdf</originalFilename><uploaded>2022-11-24T09:49:46.8097984</uploaded><type>Output</type><contentLength>988922</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-11-24T09:53:05.6884120 v2 61931 2022-11-15 Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales fcc7ece0f04577ad5f283b00dd7f52cf 0000-0002-4921-7556 Mike Seaborne Mike Seaborne true false aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 83efcf2a9dfcf8b55586999d3d152ac6 0000-0001-5225-000X Ronan Lyons Ronan Lyons true false 84f5661b35a729f55047f9e793d8798b 0000-0001-7417-2858 Sinead Brophy Sinead Brophy true false 2022-11-15 HDAT Introduction SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP), but mild or asymptomatic infections are common. Persistent symptoms following infection have been reported in CYP but subsequent healthcare use is unclear. We aim to describe healthcare use in CYP following community-acquired SARS-CoV-2 infection and identify those at risk of ongoing healthcare needs.Methods and analysis We will use anonymised individual-level, population-scale national data linking demographics, comorbidities, primary and secondary care use and mortality between 1 January 2019 and 1 May 2022. SARS-CoV-2 test data will be linked from 1 January 2020 to 1 May 2022. Analyses will use Trusted Research Environments: OpenSAFELY in England, Secure Anonymised Information Linkage (SAIL) Databank in Wales and Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 in Scotland (EAVE-II). CYP aged ≥4 and <18 years who underwent SARS-CoV-2 reverse transcription PCR (RT-PCR) testing between 1 January 2020 and 1 May 2021 and those untested CYP will be examined.The primary outcome measure is cumulative healthcare cost over 12 months following SARS-CoV-2 testing, stratified into primary or secondary care, and physical or mental healthcare. We will estimate the burden of healthcare use attributable to SARS-CoV-2 infections in the 12 months after testing using a matched cohort study of RT-PCR positive, negative or untested CYP matched on testing date, with adjustment for confounders. We will identify factors associated with higher healthcare needs in the 12 months following SARS-CoV-2 infection using an unmatched cohort of RT-PCR positive CYP. Multivariable logistic regression and machine learning approaches will identify risk factors for high healthcare use and characterise patterns of healthcare use post infection.Ethics and dissemination This study was approved by the South-Central Oxford C Health Research Authority Ethics Committee (13/SC/0149). Findings will be preprinted and published in peer-reviewed journals. Analysis code and code lists will be available through public GitHub repositories and OpenCodelists with meta-data via HDR-UK Innovation Gateway. Journal Article BMJ Open 12 11 e063271 BMJ 2044-6055 2044-6055 10 11 2022 2022-11-10 10.1136/bmjopen-2022-063271 COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). This work was also supported by The Alan Turing Institute via ‘Towards Turing 2.0’ EPSRC Grant Funding. The grant period spans 1 November 2021 to 30 September 2022. 2022-11-24T09:53:05.6884120 2022-11-15T22:54:31.0560929 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Olivia V Swann 0000-0001-7386-2849 1 Nazir I Lone 2 Ewen M Harrison 0000-0002-5018-3066 3 Laurie A Tomlinson 0000-0001-8848-9493 4 Alex J Walker 0000-0003-4932-6135 5 Mike Seaborne 0000-0002-4921-7556 6 Louisa Pollock 7 James Farrell 8 Peter S Hall 9 Sohan Seth 10 Thomas C Williams 11 Jennifer Preston 12 J. Samantha Ainsworth 13 Freya F Semple 14 J Kenneth Baillie 15 Srinivasa V Katikireddi 0000-0001-6593-9092 16 Ashley Akbari 0000-0003-0814-0801 17 Ronan Lyons 0000-0001-5225-000X 18 Colin R Simpson 0000-0002-5194-8083 19 Malcolm G Semple 20 Ben Goldacre 0000-0002-5127-4728 21 Sinead Brophy 0000-0001-7417-2858 22 Aziz Sheikh 23 Annemarie B Docherty 24 61931__25885__28f3ad11ed614fcb96afb2f4cca8c987.pdf 61931.pdf 2022-11-24T09:49:46.8097984 Output 988922 application/pdf Version of Record true © Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license true eng https://creativecommons.org/licenses/by/4.0/ |
title |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
spellingShingle |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales Mike Seaborne Ashley Akbari Ronan Lyons Sinead Brophy |
title_short |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
title_full |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
title_fullStr |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
title_full_unstemmed |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
title_sort |
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales |
author_id_str_mv |
fcc7ece0f04577ad5f283b00dd7f52cf aa1b025ec0243f708bb5eb0a93d6fb52 83efcf2a9dfcf8b55586999d3d152ac6 84f5661b35a729f55047f9e793d8798b |
author_id_fullname_str_mv |
fcc7ece0f04577ad5f283b00dd7f52cf_***_Mike Seaborne aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari 83efcf2a9dfcf8b55586999d3d152ac6_***_Ronan Lyons 84f5661b35a729f55047f9e793d8798b_***_Sinead Brophy |
author |
Mike Seaborne Ashley Akbari Ronan Lyons Sinead Brophy |
author2 |
Olivia V Swann Nazir I Lone Ewen M Harrison Laurie A Tomlinson Alex J Walker Mike Seaborne Louisa Pollock James Farrell Peter S Hall Sohan Seth Thomas C Williams Jennifer Preston J. Samantha Ainsworth Freya F Semple J Kenneth Baillie Srinivasa V Katikireddi Ashley Akbari Ronan Lyons Colin R Simpson Malcolm G Semple Ben Goldacre Sinead Brophy Aziz Sheikh Annemarie B Docherty |
format |
Journal article |
container_title |
BMJ Open |
container_volume |
12 |
container_issue |
11 |
container_start_page |
e063271 |
publishDate |
2022 |
institution |
Swansea University |
issn |
2044-6055 2044-6055 |
doi_str_mv |
10.1136/bmjopen-2022-063271 |
publisher |
BMJ |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
Introduction SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP), but mild or asymptomatic infections are common. Persistent symptoms following infection have been reported in CYP but subsequent healthcare use is unclear. We aim to describe healthcare use in CYP following community-acquired SARS-CoV-2 infection and identify those at risk of ongoing healthcare needs.Methods and analysis We will use anonymised individual-level, population-scale national data linking demographics, comorbidities, primary and secondary care use and mortality between 1 January 2019 and 1 May 2022. SARS-CoV-2 test data will be linked from 1 January 2020 to 1 May 2022. Analyses will use Trusted Research Environments: OpenSAFELY in England, Secure Anonymised Information Linkage (SAIL) Databank in Wales and Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 in Scotland (EAVE-II). CYP aged ≥4 and <18 years who underwent SARS-CoV-2 reverse transcription PCR (RT-PCR) testing between 1 January 2020 and 1 May 2021 and those untested CYP will be examined.The primary outcome measure is cumulative healthcare cost over 12 months following SARS-CoV-2 testing, stratified into primary or secondary care, and physical or mental healthcare. We will estimate the burden of healthcare use attributable to SARS-CoV-2 infections in the 12 months after testing using a matched cohort study of RT-PCR positive, negative or untested CYP matched on testing date, with adjustment for confounders. We will identify factors associated with higher healthcare needs in the 12 months following SARS-CoV-2 infection using an unmatched cohort of RT-PCR positive CYP. Multivariable logistic regression and machine learning approaches will identify risk factors for high healthcare use and characterise patterns of healthcare use post infection.Ethics and dissemination This study was approved by the South-Central Oxford C Health Research Authority Ethics Committee (13/SC/0149). Findings will be preprinted and published in peer-reviewed journals. Analysis code and code lists will be available through public GitHub repositories and OpenCodelists with meta-data via HDR-UK Innovation Gateway. |
published_date |
2022-11-10T04:21:09Z |
_version_ |
1763754397441982464 |
score |
11.036837 |